DOES THE CHARACTER OF HYPERTENSION AND MODE OF THERAPY DETERMINE CHANGES IN THE QUALITY OF LIFE?
DOI:
https://doi.org/10.12775/4095Keywords
hypertension, therapy, quality of lifeAbstract
Introduction. The study of factors which determine changes of life quality in patients with arterial hypertension is crucial to relevancy and effectiveness of secondary activities which are implemented for patients' care. Does the character of hypertension and mode of therapy determine changes in the quality of life? For many years, the improvement in quality of life has been taken into account. Apart from activities eliminating the symptoms of disease and prolonging the duration of patient's life, it is essential to improve the quality of life. Conducting research aiming at determining factors allows taking proper preventive and reparative steps.
The aim of the study is to determine:
- what the level of quality of life in patients with arterial hypertension is,
- if duration of illness influences changes in the quality of life,
- if differences in quality of life reflect severity of hypertension,
- if the type of leading symptom and its intensity change the quality of life.
Materials and methods. The studied group comprised of 185 patients with arterial hypertension. The mean age of patients was 55.6±14.2 years. Diagnostics survey was applied as the analysis method. The self-developed ‘Quality of Life Questionnaire’ and ‘Interview Questionnaire’ were exploited. The study was performed in the area of city of Bydgoszcz.
The results showed that mean Quality of Life [QoL] in patients was 0.58, where 0 represented the lowest and 1.0 the highest level of QoL. The lowest level of QoL (0.54) was demonstrated by patients with long history of hypertension. In patients with short duration of disease the Quality of Life was 0.69. The level of hypertension had the most important influence on the Quality of Life. The dependence between the leading symptom and the quality of life was not demonstrated. The level of intensity of the leading symptom of the disease revealed to be the most strongly influencing factor.
Conclusions. 1. The quality of life in patients with arterial hypertension is significantly low. 2. The duration of the disease influences the patients' quality of life. 3. The mode of therapy is not a relevant factor causing changes of life quality. 4. The intensity of the leading symptom determines the quality of life in patients.
References
Robinson JD., Segal R., Lopez LM. et al.: Impact of a pharmaceutical care intervention on blood pressure in a chain pharmacy practice. Annales of Pharmacotherapy, 2010; 44(1): 88-96. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000273620900010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3
Afsar B., Elsurer R., Sezer S., Ozdemir FN.: Nondipping phenomenon and quality of life: are they related in essential hypertensive patients? Clinical & Experimental Hypertension, 2010; 32(2):105-12. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000276416000006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3
Saboya PM., Zimmermann PR., Bodanese LC.: Association between anxiety or depressive symptoms and arterial hypertension, and their impact on the quality of life. International Journal of Psychiatry in Medicine, 2010; 40(3):307-20. DOI: http://dx.doi.org/10.2190/PM.40.3.f
Degl'Innocenti A., Elmfeldt D., Hofman A., Health-realted quality of life during treatment of elderly patients with hypertension: results from the Study on Cognition and Prognosis in the Elderly (SCOPE). J Hum Hypertens 2004; 18: 239-245. DOI: http://dx.doi.org/10.1038/sj.jhh.1001657
Kucharska A., Jeznach-Steinhagen A., Sińska B.: Znaczenie diety w leczeniu nadciśnienia. Kardiol. na co Dzień 2010; 5: 29-32.
Gaciong Z., Wilczko J., Postępowanie w nadciśnieniu tętniczym-aktualizacja zaleceń Europejskiego Towarzystwa Nadciśnienia Tętniczego Przew. Lek. 2010; 4,13: 14-18.
Widecka K., Grodzicki T., Narkiewicz K., Tykarski A., Dziwura J. (zespół redakcyjny). Zasady postępowania w nadciśnieniu tętniczym - 2011 rok Wytyczne Polskiego Towarzystwa Nadciśnienia Tętniczego. Nadciśn. Tętn., 2011; 15(2): 55-82.
Kawecka-Jaszcz K., Klocek M., Jakość życia chorych na nadciśnienie tętnicze [w]: Andrzej Więcek (red.), Franciszek Kokot (red): Postępy w nefrologii i nadciśnieniu tętniczym. Med. Prakt. 2007; 6: 154-156.
Klocek M., Brzozowska-Kiszka M., Rajzer M., Kawecka-Jaszcz K. Zmiany w jakości życia chorych na nadciśnienie tętnicze w czasie telemonitorowania domowych pomiarów ciśnienia. Nadciśn. Tętn., 2010; 14(2): 120-127.
Szczęch R., Szyndler A., Wierucki Ł. i wsp. Jak poprawić skuteczność terapii nadciśnienia tętniczego? Doświadczenia z programu edukacji pacjentów w ramach Polskiego Projektu 400 Miast. Arterial Hypertension 2006; 10(5): 350-361.
Woźnicka L., Posadzy-Małaczyńska A., Leśkiewicz G., Głuszek J. Ocena jakości życia pacjentów chorujących na nadciśnienie tętnicze według ankiety SF-36. Nadciśn. Tętn., 2008; 12(2): 109-117.
Erickson S. R., Williams B. C., Gruppen L. D. Relationship between symptoms and health-related quality of life in patients treated for hypertension. Pharmacotherapy 2004; 24(3): 344-350. DOI: http://dx.doi.org/10.1592/phco.24.4.344.33177, http://www.ncbi.nlm.nih.gov/pubmed/15040647
Wizner B., Gaciong Z., Narkiewicz K., Grodzicki T. Zwiększenie skuteczności terapii hipotensyjnej u pacjentów z nadciśnieniem tętniczym dzięki edukacji przez SMS. Nadciśn. Tętn., 2009; 13(3): 147-157.
Published
How to Cite
Issue
Section
Stats
Number of views and downloads: 0
Number of citations: 0
